Liquid Biopsies in Solid Tumors
This volume, with chapters written by experts in the field of cancerous tumors, details the key factors associated with liquid biopsies in solid tumors: blood-based diagnostics; circulating tumor cells; enumeration and molecular analysis (association with
- PDF / 3,693,137 Bytes
- 165 Pages / 439.42 x 683.15 pts Page_size
- 90 Downloads / 211 Views
Massimo Cristofanilli Editor
Liquid Biopsies in Solid Tumors
7 CTCs and ctDNA: Two Tales of a Complex Biology
137
117. Lipson EJ, Velculescu VE, Pritchard TS et al (2014) Circulating tumor DNA analysis as a realtime method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade. J Immunother Cancer 2:42. doi:10.1186/s40425-014-0042-0 118. Bettegowda C, Sausen M, Leary RJ et al (2014) Detection of circulating tumor DNA in earlyand late-stage human malignancies. Sci Transl Med 6 . doi:10.1126/scitranslmed. 3007094224ra24–224ra24 119. Sacher AG, Paweletz C, Dahlberg SE et al (2016) Prospective validation of rapid plasma genotyping for the detection of EGFR and KRAS mutations in advanced lung cancer. JAMA Oncol 2(8):1014–1022. doi:10.1001/jamaoncol.2016.0173 120. Lanman RB, Mortimer SA, Zill OA et al (2015) Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA. PLoS One 10:e0140712 121. Kinde I, Wu J, Papadopoulos N et al (2011) Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci U S A 108:9530–9535. doi:10.1073/ pnas.1105422108 122. Newman AM, Bratman SV, To J et al (2014) An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med 20:548–554. doi:10.1038/nm.3519 123. Leary RJ, Sausen M, Kinde I et al (2012) Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med 4:162ra154– 162ra154. doi:10.1126/scitranslmed.3004742 124. Newman AM, Lovejoy AF, Klass DM et al (2016) Integrated digital error suppression for improved detection of circulating tumor DNA. Nat Biotechnol. doi:10.1038/nbt.3520 125. Fujimoto J, Wedge DC, Song X et al (2014) Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346:256–259. doi:10.1126/ science.1256930 126. Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892. doi:10.1056/ NEJMoa1113205 127. Vijg J (2014) Somatic mutations, genome mosaicism, cancer and aging. Curr Opin Genet Dev 26:141–149. doi:10.1016/j.gde.2014.04.002 128. Behjati S, Huch M, van Boxtel R et al (2014) Genome sequencing of normal cells reveals developmental lineages and mutational processes. Nature 513:422–425. doi:10.1038/nature13448 129. Tomasetti C, Vogelstein B (2015) Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347:78–81. doi:10.1073/pnas.1221724110 130. Soares JP, Cortinhas A, Bento T, Leitão JC (2014) Aging and DNA damage in humans: a meta-analysis study. Aging (Albany NY) 6(6):432–439 131. Genovese G, Kähler AK, Handsaker RE et al (2014) Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 371:2477–2487. doi:10.1056/ NEJMoa1409405 132. Laurie CC, Laurie CA, Rice K et al (2012)
Data Loading...
